Michael Mollerus
Lawyers
Filters
General Mills €1 billion notes offering
The investment-grade notes are due 2030 and 2034
Intra-Cellular Therapies $500 million stock offering
The shares are listed on the Nasdaq Global Select Market
Stoke Therapeutics $125 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Select Market
Cleveland-Cliffs $825 million notes offering and concurrent tender offer
The high-yield notes are due 2032
GFL Environmental $723.45 million secondary offering
The subordinate voting shares are dual-listed on the NYSE and the Toronto Stock Exchange
Aon $6 billion senior notes offering
The investment-grade offering comprises five tranches
Amer Sports $800 million senior secured notes offering
We advised Amer Sports on the high-yield notes offering
Amer Sports $1.2 billion credit facilities and €700 million credit facility
We advised the borrowers on the financing transactions
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Azul $148.7 million secured notes reopening
The senior secured notes are due 2028